124 related articles for article (PubMed ID: 2468864)
1. Prolonged calcium channel blocker therapy of hypertension.
Weber MA
J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S16-21. PubMed ID: 2468864
[TBL] [Abstract][Full Text] [Related]
2. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
Weber MA; Drayer JI
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1077-84. PubMed ID: 6085371
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive therapy with nitrendipine: comparison with hydrochlorothiazide and propranolol.
Massie BM
J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S55-8. PubMed ID: 2468874
[TBL] [Abstract][Full Text] [Related]
4. Long-term efficacy and safety of nitrendipine in severe essential hypertension.
Burris JF; Nash DT; Mroczek WJ
J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S157-60. PubMed ID: 2468863
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of a new calcium antagonist in severe hypertension.
Burris JF; Santangelo RP; Mroczek WJ
J Clin Pharmacol; 1986; 26(8):593-7. PubMed ID: 3793949
[TBL] [Abstract][Full Text] [Related]
6. Effect of the calcium channel blocker nitrendipine on left ventricular mass in patients with hypertension.
Drayer JI; Hall WD; Smith VE; Weber MA; Wollam GL; White WB
Clin Pharmacol Ther; 1986 Dec; 40(6):679-85. PubMed ID: 3780130
[TBL] [Abstract][Full Text] [Related]
7. Nitrendipine in severe hypertension. Satellite symposium on calcium antagonists.
Mroczek WJ; Burris JF; Allenby KS
Hypertension; 1988 Feb; 11(2 Pt 2):I225-8. PubMed ID: 2894357
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of nitrendipine in patients with severe hypertension: a multiclinic study.
Jain AK; McMahon FG; Ryan JR; Maronde R; Vlachakis N; Mroczek W
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1053-9. PubMed ID: 6085366
[TBL] [Abstract][Full Text] [Related]
9. Similar efficacy of nitrendipine in young and elderly hypertensive patients.
Mehta J; Lopez LM; Deedwania PC; Fagan TC; Sternlieb CM; Vlachakis ND; Birkett JP; Schwartz LA
Am J Cardiol; 1987 Nov; 60(13):1096-100. PubMed ID: 3314459
[TBL] [Abstract][Full Text] [Related]
10. Long-term antihypertensive effects and safety of nitrendipine in patients with mild, moderate, and severe hypertension.
Kann J
J Clin Pharmacol; 1987 Dec; 27(12):945-50. PubMed ID: 3437066
[TBL] [Abstract][Full Text] [Related]
11. A comparison of felodipine and propranolol as additions to hydrochlorothiazide in the treatment of hypertension.
Carle WK; Latta D; Lees CT; Lough JR; Pender J; Ross JR; Sefton S; Peers EM; Richardson PD
Eur J Clin Pharmacol; 1988; 34(2):115-8. PubMed ID: 3289947
[TBL] [Abstract][Full Text] [Related]
12. Felodipine in hypertensive patients. A dose finding study in patients refractory to beta-blocker monotherapy.
Sluiter HE
Drugs; 1987; 34 Suppl 3():97-106. PubMed ID: 2894980
[TBL] [Abstract][Full Text] [Related]
13. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
Jackson B; Morgan TO; Gibson J; Anderson A
Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971
[TBL] [Abstract][Full Text] [Related]
14. Treatment of hypertension in the elderly with a new calcium channel blocking drug, nitrendipine.
Byyny RL; LoVerde M; Mitchell W
Am J Med; 1989 Jan; 86(1):49-55. PubMed ID: 2642658
[TBL] [Abstract][Full Text] [Related]
15. Randomised, double blind, multicentre comparison of hydrochlorothiazide, atenolol, nitrendipine, and enalapril in antihypertensive treatment: results of the HANE study. HANE Trial Research Group.
Philipp T; Anlauf M; Distler A; Holzgreve H; Michaelis J; Wellek S
BMJ; 1997 Jul; 315(7101):154-9. PubMed ID: 9251545
[TBL] [Abstract][Full Text] [Related]
16. Nitrendipine monotherapy in severe hypertension.
Mroczek WJ; Burris JF
Angiology; 1988 Jan; 39(1 Pt 2):81-6. PubMed ID: 3341610
[TBL] [Abstract][Full Text] [Related]
17. Nitrendipine treatment in so-called therapy-resistant arterial hypertension; effect as monotherapy and in combination with propranolol on blood pressure, heart rate, other hemodynamic parameters, plasma renin activity, and catecholamines.
Faulhaber HD; Gruner R; Homuth V; Naumann E; Menz M; Hartrodt W; Schmidt J; Mohnike W
J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S146-8. PubMed ID: 2468860
[TBL] [Abstract][Full Text] [Related]
18. A double-blind comparative study of doxazosin and nitrendipine in patients with mild-to-moderate essential hypertension.
Nechwatal W; Berger J; Blumrich W; Bouzo H; Brandl K; Braun S; Laukaitis A; Müller G; Ryba W; Schreiegg J
Am Heart J; 1988 Dec; 116(6 Pt 2):1806-14. PubMed ID: 2904755
[TBL] [Abstract][Full Text] [Related]
19. Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension.
Schoenberger JA; Glasser SP; Ram CV; McMahon SG; Vanov SK; Leibowitz DA
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1105-8. PubMed ID: 6085376
[TBL] [Abstract][Full Text] [Related]
20. Comparison of nitrendipine and hydrochlorothiazide for systemic hypertension.
Giles TD; Sander GE; Roffidal LC; Thomas MG; Given MB; Quiroz AC
Am J Cardiol; 1987 Jul; 60(1):103-6. PubMed ID: 3300241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
